The Latest Breaking News from Pfizer

Reuters reported that two patients found relief from long COVID after taking Pfizer Inc's (NYSE:PFE) antiviral Paxlovid, including a researcher who tested it on herself. Long COVID is estimated to affect up to 30% of people infected with the coronavirus. It can last for months.  More than 200 symptoms have been associated with the…

Researchers from King's College London have found a way to stimulate the creation of healthy heart cells - which can then be delivered to the muscle using the same technology used with the Moderna and Pfizer Covid vaccines

If federal regulators verify the claims, children over the age of five could gain access to boosters.

Pfizer wants to expand its COVID-19 booster shots to healthy 5- to 11-year-olds

A third dose of the COVID-19 vaccine from Pfizer Inc and BioNTech produced significant protection against the Omicron variant of the coronavirus in healthy children ages 5 to 11, the companies said on Thursday.

The Food and Drug Administration and the Centers for Disease Control and Prevention recently authorized a second booster shot of the Pfizer/BioNTech and Moderna COVID-19 vaccines for those age 50 and older. The recommendation follows a study out of Israel recently published in The New England Journal of Medicine.

Welsh immunologist says we'd be better off vaccinating the rest of the world to protect against new variants than giving young, healthy people a fourth shot

Michelle Flower, from Sheffield, says she had a rare adverse reaction to having a Pfizer Covid booster in January that led to her "ageing 20 years in just three days"

The woman is adamant she is not an anti-vaxxer and is keen to make people aware of alleged risks